Extrahepatic metabolism of ibrutinib

Ibrutinib is a first-in-class Bruton’s kinase inhibitor used in the treatment of multiple lymphomas. In addition to CYP3A4-mediated metabolism, glutathione conjugation can be observed. Subsequently, metabolism of the conjugates and finally their excretion in feces and urine occurs. These metabolites...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Invest New Drugs
मुख्य लेखकों: Rood, Johannes J. M., Jamalpoor, Amer, van Hoppe, Stephanie, van Haren, Matthijs J., Wasmann, Roeland E., Janssen, Manoe J., Schinkel, Alfred H., Masereeuw, Rosalinde, Beijnen, Jos H., Sparidans, Rolf W.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer US 2020
विषय:
Preclinical Studies
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851014/
https://ncbi.nlm.nih.gov/pubmed/32623551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-020-00970-x
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन